Evidence map›Paper›PMID 34880494›Full record

ArticleNature2021

β-NAD as a building block in natural product biosynthesis.

Lena Barra, Takayoshi Awakawa, Kohei Shirai, Zhijuan Hu, Ghader Bashiri, Ikuro Abe

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Pyridoxal 5'-Phosphate-Dependent Enzymatic Decarboxylative Annulation.Journal of the American Chemical Society · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Discovery of a novel methionine biosynthetic routeApplied and environmental microbiology · 2024
    Article
  19. Nature-Inspired Radical Pyridoxal-Mediated C-C Bond Formation.Journal of the American Chemical Society · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Lena Barra *Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6566-4180
Takayoshi Awakawa *Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. awakawa@mol.f.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-2575-3175
Kohei ShiraiGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Zhijuan HuGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan.
Ghader BashiriLaboratory of Molecular and Microbial Biochemistry, School of Biological Sciences, The University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-5092-3749
Ikuro AbeGraduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. abei@mol.f.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-3640-888X
The University of Tokyo · JPUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstratctβ-Nicotinamide adenine dinucleotide (β-NAD) is a pivotal metabolite for all living organisms and functions as a diffusible electron acceptor and carrier in the catabolic arms of metabolism

Indexed as

Biological ProductsNADCatalysisNiacinamideSignal TransductionBiological ProductsNADNiacinamide

Identifiers

PMID34880494
OpenAlexW4200509090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.